Stock Financial Ratios


HRTX / Heron Therapeutics, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price15.95
Volume1,015,400.00
Market Cap ($M)847.85
Enterprise Value ($M)838.45
Book Value ($M)-21.25
Book Value / Share-0.56
Price / Book21.17
NCAV ($M)-1.76
NCAV / Share-0.05
Price / NCAV9.23
Income Statement (mra) ($M)
Revenue1.28
EBITDA-170.91
Net Income-173.14
Balance Sheet (mrq) ($M)
Cash & Equivalents65.52
Cash / Share1.73
Assets141.21
Liabilities78.14
Quick Ratio0.67
Current Ratio0.81
Management Effectiveness (mra)
Return on Invested Capital (ROIC)8.15
Return on Assets (ROA)-4.83
Return on Equity (ROE)8.15
Identifiers and Descriptors
CUSIP427746102
Central Index Key (CIK)818033
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
427746952
427746902
Share Statistics
Common Shares Outstanding (M)54.50
Scoring Models
Piotroski F Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Retained Earnings Per Share-19.01
Assets Current Per Share3.58
Minority Interest Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Liabilities Per Share2.06
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Inventory Raw Materials Per Share0.00
Property Plant And Equipment Net Per Share0.14
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Cash Per Share1.73
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accounts Receivable Per Share0.76
Liabilities Current Per Share1.25
Property Plant And Equipment Per Share0.14
Assets Other Non Current Per Share0.01
Inventory Work In Progress Per Share0.00
Liabilities And Stock Equity Per Share3.12
Assets Per Share3.72
Long Term Debt Per Share0.00
Additional Paid In Capital Per Share20.05
Treasury Stock Per Share0.00
Equity Per Share1.06
Debt Per Share0.00
Cash And Equivalents Per Share1.73
Intangibles Per Share0.00
Goodwill Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Inventory Per Share0.14

Related News Stories

Biotech Forum Daily Digest: What Heron's FDA Approval Means

2017-11-17 seekingalpha
The small biotech sector staged an almost two percent 'relief rally' Thursday after falling some 10% over the past month. (73-3)

Heron Therapeutics: Wait For A Dip Before Jumping In

2017-11-17 seekingalpha
On Nov. 9, Heron Therapeutics received FDA approval of Cinvanti, its anti-nausea medication for patients undergoing chemotherapy. (18-0)

La Jolla: Red Flags And A Vastly Overestimated Market Create A Compelling Short

2017-11-16 seekingalpha
The market potential for La Jolla's primary asset, a treatment for hypo-tension in Septic Shock patients, is severely overestimated in my opinion. (250-1)

CUSIP: 427746102